Actuate Therapeutics ACTU
NASDAQ ACTU
$0.52 -0.04 (-7.14%)
At close: Oct 22, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Net Shares Issued and Repurchased (2024 - 2025)

Updated

Analysis

Actuate Therapeutics (ACTU) Net Shares Issued and Repurchased (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -966.00 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -9.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 6.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -346.00 Mn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Actuate Therapeutics 12.49 Mn -28.52 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 1.63 Mn
Dec 31, 2024 -109,412.00
Sep 30, 2024 23.96 Mn
API Access

Actuate Therapeutics Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=ACTU&period=max&api_key=YOUR_API_KEY